Stocksigma LogoStocksigma Logo

SPARC Secures Favourable CESTAT Ruling for Rs 27.51 Crore CENVAT Credit Refund

Sun Pharma Advanced Research Company Limited (SPARC) received a favourable ruling from the Customs, Excise & Service Tax Appellate Tribunal (CESTAT)

SPARC Secures Favourable CESTAT Ruling for Rs 27.51 Crore CENVAT Credit Refund

Sun Pharma Advanced Research Company Ltd 路 Others (Uncategorized) 路 04 Oct 2026, 6:08 pm

SPARC Secures Favourable CESTAT Ruling for Rs 27.51 Crore CENVAT Credit Refund Sun Pharma Advanced Research Company Limited (SPARC) received a favourable ruling from the Customs, Excise & Service Tax Appellate Tribunal (CESTAT), Mumbai. The Tribunal dismissed the Revenue's appeal and upheld the Order-in-Appeal dated 27th Apr'18. Consequently, the Tribunal confirmed the company's entitlement to a refund of accumulated CENVAT credit amounting to Rs 2,751 Lakhs (Rs 27.51 crore), along with applicable consequential interest, effectively concluding the ongoing tax dispute in favour of SPARC.

Original exchange filing (PDF)

More announcements from Sun Pharma Advanced Research Company Ltd

All Sun Pharma Advanced Research Company Ltd announcements